Cargando…
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
First reports of cases and case series of COVID-19-associated pulmonary aspergillosis (CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely due to the fact that CAPA was, and still remains, challenging to diagnose in patients with COVID-19-associated acute respirator...
Autores principales: | Egger, Matthias, Bussini, Linda, Hoenigl, Martin, Bartoletti, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027069/ https://www.ncbi.nlm.nih.gov/pubmed/35448621 http://dx.doi.org/10.3390/jof8040390 |
Ejemplares similares
-
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
por: Hoenigl, Martin, et al.
Publicado: (2023) -
Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis
por: Egger, Matthias, et al.
Publicado: (2022) -
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021) -
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
por: Gatti, Milo, et al.
Publicado: (2023) -
Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)